Chinese Journal of Cancer Research（ISSN号1000-9604）是由中国抗癌协会主办、Springer Nature出版的英文期刊，出版地为北京，双月刊，非OA（开放获取）期刊，已被SCI收录，2022年影响因子为4.4，中科院分区为医学大类3区。该杂志聚焦肿瘤学领域，涵盖基础研究、临床诊疗、流行病学及转化医学等方向，尤其关注中国及亚洲地区高发肿瘤的研究，发文特点包括多学科交叉、注重原创性与临床实用性。杂志质量较高，编委团队以国内权威专家为主，审稿流程规范，但需注意其地域性研究偏重可能对国际普适性形成一定限制，且非OA模式可能影响传播广度。总体而言，该期刊是肿瘤学领域具有一定影响力的专业刊物，适合关注区域性肿瘤研究的学者投稿。
Prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery: Final results of a phase II trial
2025-03-06T11:38:56Z
Clinicopathological and molecular features of HR+/HER2− breast cancer patients with distinct endocrine resistance patterns
2025-03-06T11:38:56Z
Integrated analysis of single-cell and bulk transcriptomes uncovers clinically relevant molecular subtypes in human prostate cancer
2025-03-06T11:38:56Z
CT-based radiomics-deep learning model predicts occult lymph node metastasis in early-stage lung adenocarcinoma patients: A multicenter study
2025-03-06T11:38:56Z
Adaptive neoadjuvant endocrine therapy screens out prime population of ribociclib intensive adjuvant therapy
2025-03-06T11:38:56Z
Improving neuroblastoma risk prediction through a polygenic risk score derived from genome-wide association study-identified loci
2025-03-06T11:38:56Z
Deep learning-based multi-task prediction of response to neoadjuvant chemotherapy using multiscale whole slide images in breast cancer: A multicenter study
2025-03-06T11:38:56Z
Corrigendum to National validation of laparoscopic approach for locally advanced gastric cancer: Comparison of a randomized controlled trial and real-world practice results
2025-03-06T11:38:56Z
Molecular features of gastroenteropancreatic neuroendocrine carcinoma: A comparative analysis with lung neuroendocrine carcinoma and digestive adenocarcinomas
2024-03-05T11:25:39Z
Microbiota and urinary tumor immunity: Mechanisms, therapeutic implications, and future perspectives
2025-01-07T07:49:29Z
New roles of tumor-derived exosomes in tumor microenvironment
2024-05-15T13:52:24Z
Clinicopathological significance and immunotherapeutic outcome of claudin 18.2 expression in advanced gastric cancer: A retrospective study
2024-03-05T16:25:39Z
Hypoxic tumor microenvironment: Destroyer of natural killer cell function
2024-05-15T13:52:24Z
Genomic characterization of peritoneal lavage cytology-positive gastric cancer
2024-03-05T16:25:39Z
Postoperative chemoradiotherapy with capecitabine and oxaliplatin vs. capecitabine for pathological stage N2 rectal cancer
2024-11-08T10:17:59Z
